Tivozanib response prediction

Details for Australian Patent Application No. 2010308492 (hide)

Owner AVEO Pharmaceuticals, Inc.

Inventors Lin, Jie; Feng, Bin; Robinson, Murray; Jiang, Feng; Sun, Xiaojian

Agent Cullens

Pub. Number AU-A-2010308492

PCT Pub. Number WO2011/049645

Priority 61/253,036 19.10.09 US; 12/645,355 22.12.09 US

Filing date 3 June 2010

Wipo publication date 28 April 2011

International Classifications

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/049645 Priority application(s): WO2011/049645

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010308495-Method for quantitatively assessing connectivity for well pairs at varying frequencies

2010308489-Contact lens sets and methods to prevent or slow progression of myopia or hyperopia